Latest News
- Radiation therapy can enhance effectiveness of immunotherapy in people with advanced lung cancer, UCLA study finds
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
May 25, 2017 6:30 AM
detail - Tai chi relieves insomnia in breast cancer survivors
If you have had insomnia, you know worrying about sleep makes it even harder to fall asleep. For the 30 percent of breast cancer survivors who have insomnia, sleepless nights can lead to depression, fatigue and a heightened risk of disease.
May 15, 2017 9:00 AM
detail - Dendritic cell vaccine augments the immune system in people with non-small cell lung cancer
UCLA scientists have discovered a dendritic cell vaccine that amplifies the response of the immune system in people with non-small cell lung cancer, the most common form of lung cancer.
May 11, 2017 9:00 AM
detail - UCLA researchers design process to better understand how advanced melanoma adapts to immunotherapy
A new study by scientists at the UCLA Jonsson Comprehensive Cancer Center could be a significant step toward understanding how certain cases of advanced melanoma shield themselves from pembrolizumab, the FDA-approved treatment that harnesses the immune system to attack the disease.
May 09, 2017 9:00 AM
detail - Combination therapy could provide new treatment option for ovarian cancer
Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer — the most common subtype of ovarian cancer — after standard treatment with the chemotherapy drug carboplatin.
May 04, 2017 11:30 AM
detail - UCLA physician-scientist awarded collaborative grant to study use of genomics in treatment-resistant cancers
UCLA researcher Dr. Siwen Hu-Lieskovan has been awarded the Phillip A. Sharp Innovation in Collaboration Award from Stand Up To Cancer (SU2C) to fund her work using genomics to better understand how melanoma and other cancers can become resistant to immunotherapy.
May 03, 2017 12:00 PM
detail - Renowned UCLA physician-scientist honored for commitment to pediatric cancer care
Dr. Jacqueline Casillas, clinical director of UCLA’s Pediatric Cancer Survivorship Program and associate director of the UCLA-LIVESTRONG Survivorship Center of Excellence, has received the 2017 Unmasque “Caregiver” Award from the The Samfund organization for her decades-long commitment to young pediatric cancer survivorship.
May 01, 2017 8:00 AM
detail - FDA approves new drug to treat hepatocellular carcinoma, the most common form of liver cancer
The U.S. Food & Drug Administration today approved a new drug to treat people with hepatocellular carcinoma, the most common form of liver cancer. The drug, regorafenib, is the first and only therapy approved by the FDA in over a decade to show significant improvement in survival for patients with the disease after standard treatments have failed.
April 27, 2017 1:00 PM
detail - UCLA physician-scientist named to Association of American Physicians
Dr. Michael Teitell has been named to the prestigious Association of American Physicians. Election to membership is among the most widely recognized international measures of scholarly excellence in academic medicine.
April 21, 2017 12:00 PM
detail - Breast cancer survivors who are provided a tailored care plan are more likely to receive recommended care, UCLA study finds
Physicians of low-income breast cancer survivors are more likely to implement recommended survivorship care if the survivors also receive counseling and a tailored survivorship care plan, a study led by UCLA researchers has found.
April 18, 2017 1:00 PM
detail - UCLA researcher awarded prestigious grant to study role of molecule in prostate cancer
UCLA researcher Andrew Goldstein has been awarded a research scholar grant from the American Cancer Society to fund his work on prostate cancer. Goldstein is an assistant professor in residence in the departments of Urology and Molecular, Cell and Developmental Biology, and a member of UCLA’s Jonsson Comprehensive Cancer Center and Broad Stem Cell Research Center.
April 18, 2017 9:00 AM
detail - Who is the new face of throat cancer?
Younger and younger people are getting diagnosed with throat cancer each year, watch as UCLA's Dr. Abie Mendelsohn explains why.
April 17, 2017 3:00 PM
detail - UCLA scientists combine a peptide with a nano cancer drug formulation to improve treatment effectiveness and prevent metastasis in pancreatic cancer
UCLA scientists have unlocked an important mechanism that allows chemotherapy-carrying nanoparticles to directly access pancreatic cancer tumors, thereby improving the ability to kill cancer cells and hence leading to more effective treatment outcome of the disease.
April 17, 2017 1:00 PM
detail - UCLA scientist honored for advancing the understanding of how metabolism affects cancer
The AAAS has announced the winners of the prestigious 2017 AAAS Martin and Rose Wachtel Cancer Research Award, recognizing UCLA scientist Dr. Heather Christofk for her pioneering research into how metabolism can regulate and drive cancer.
April 11, 2017 11:00 AM
detail - UCLA Jonsson Comprehensive Cancer Center scientists to present on latest cancer research advancements at AACR 2017
Scientists with UCLA’s Jonsson Comprehensive Cancer Center will present some of the most highly anticipated research at the 2017 American Association for Cancer Research (AACR) Annual Meeting. The event takes place at the Walter E. Washington Convention Center in Washington, D.C. from April 1 through April 5.
March 29, 2017 8:00 AM
detail - Targeting cancer stem cells improves treatment effectiveness and prevents metastasis
Targeting cancer stem cells may be a more effective way to overcome cancer resistance and prevent the spread of squamous cell carcinoma—the most common head and neck cancer and the second-most common skin cancer—according to a new study by cancer researchers at the UCLA School of Dentistry
March 09, 2017 9:00 AM
detail - Guidelines for treating brain metastases should be overhauled, UCLA study finds
An extensive study by UCLA researchers looking at current practice patterns among doctors treating people with three or more brain metastases—cancer cells that have spread from a primary tumor located in a different part of the body—found significant variation in treatment strategies, bringing to light the need for further research to guide physicians' decision making.
March 01, 2017 9:00 AM
detail